Evidence map›Paper›PMID 31879349›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

The

Julia Lienard, Esther Nobs, Victoria Lovins, Elin Movert, Christine Valfridsson, Fredric Carlsson

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 1 synthesis or guideline pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Pathogens (Basel, Switzerland) · 2025
    Review
  12. Review
  13. Journal of bacteriology · 2025
    Review
  14. Mitochondrial DNA signals driving immune responses: Why, How, Where?Cell communication and signaling : CCS · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. PE/PPE Proteome and ESX-5 Substrate Spectrum inInternational journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Julia LienardDepartment of Biology, Section for Molecular Cell Biology, Lund University, 223 62 Lund, Sweden.
Esther NobsDepartment of Biology, Section for Molecular Cell Biology, Lund University, 223 62 Lund, Sweden.
Victoria LovinsDepartment of Biology, Section for Molecular Cell Biology, Lund University, 223 62 Lund, Sweden.
Elin MovertDepartment of Experimental Medical Science, Section for Immunology, Lund University, 221 84 Lund, Sweden.
Christine ValfridssonDepartment of Experimental Medical Science, Section for Immunology, Lund University, 221 84 Lund, Sweden.
Fredric CarlssonDepartment of Biology, Section for Molecular Cell Biology, Lund University, 223 62 Lund, Sweden; fredric.carlsson@biol.lu.se.
Lund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following mycobacterial entry into macrophages the ESX-1 type VII secretion system promotes phagosomal permeabilization and type I IFN production, key features of tuberculosis pathogenesis. The current model states that the secreted substrate ESAT-6 is required for membrane permeabilization and that a subsequent passive leakage of extracellular bacterial DNA into the host cell cytosol is sensed by the cyclic GMP-AMP synthase (cGAS) and stimulator of IFN genes (STING) pathway to induce type I IFN production. We employed a collection of

Indexed as

Antigens, BacterialBacterial ProteinsCell Membrane PermeabilityHost-Pathogen InteractionsInterferon Type IMacrophagesMitochondriaMycobacterium Infections, NontuberculousMycobacterium marinumPhagosomesTuberculosisType VII Secretion SystemsAntigens, BacterialBacterial ProteinsESAT-6 protein, Mycobacterium tuberculosisInterferon Type IType VII Secretion SystemsESAT-6 secretionmembrane permeabilizationmitochondrionmycobacterial pathogenesistype I interferon

Identifiers

PMID31879349
PMCPMC6969537
OpenAlexW2997805727

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.